
Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Step by step instructions to Pick the Right Sunlight powered charger Type for Your Home - 2
Interstellar comet 3I/ATLAS to pass closest to Earth on Friday - 3
Artemis 2 astronauts — now halfway to the moon — report 'burning smell' from toilet, but everything's fine - 4
Mossad unveils network of Hamas terror infrastructure across Europe - 5
Savvy Tips for Seniors Hyundai IONIQ EV
German state railway loss widens, passengers warned of trouble ahead
Watch Blue Origin's huge New Glenn rocket ace its epic landing on a ship at sea (video)
Arctic sea ice just dropped to an alarming new low
This Huge Ocean Beast Shifts Sharks’ Evolutionary Timeline
4 Sound blocking Earphones for Prevalent Sound and Solace
Shooting of MIT professor Nuno Loureiro has police searching for a suspect
He suddenly couldn't speak in space. NASA astronaut says his medical scare remains a mystery
Antivirus Programming for Exhaustive Security
China bans storing cremated remains in empty 'bone ash apartments'













